{"id":"n_bsqo53ag6as3keblqqcq","seq":9406493,"kind":"article","title":"FDA flags potential vision loss risk linked to GLP-1 drugs: What users of weight-loss medications should know","url":"https://www.livemint.com/news/us-news/fda-flags-potential-vision-loss-risk-linked-to-glp-1-drugs-what-users-of-weight-loss-medications-should-know-11794304730495.html","summary":"FDA analysis of 126 clinical trials involving 134,253 participants found higher NAION incidence among GLP-1 drug users than those taking placebos or other diabetes medications.","published":"2026-11-10T10:18:26Z","seen":"2026-11-10T10:33:02Z","lang":"en","country":"IN","source":{"id":"kite-livemint-com-6d3acc","name":"livemint.com","domain":"livemint.com"},"via":"kite-livemint-com-6d3acc","image":"https://www.livemint.com/lm-img/img/2026/11/10/1600x900/logo/weight_loss_drugs_1794305757375_w56s_1794305767441_BMiU_36253b13-863d-46d9-88df-3016579c92d4_OKMf.png","story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.88,"sentiment":"negative","tone":-0.59,"political":0.06}